Histamine-2 Receptor Antagonist [EPC]

Histamine-2 Receptor Antagonist [EPC] was reported 131532 times

These side effects are most commonly reported by patients taking drugs of the Histamine-2 Receptor Antagonist [EPC] class:

# Drug class Count
0 NAUSEA 8976
1 FATIGUE 8315
2 CHRONIC KIDNEY DISEASE 8179
3 DIARRHOEA 7876
4 DRUG INEFFECTIVE 7670
5 OFF LABEL USE 6430
6 DYSPNOEA 6391
7 HEADACHE 6059
8 ACUTE KIDNEY INJURY 5664
9 PAIN 5540
10 VOMITING 5530
11 DIZZINESS 5175
12 RENAL FAILURE 4968
13 DEATH 4435
14 PNEUMONIA 4081
15 ASTHENIA 3971
16 PYREXIA 3964
17 RASH 3899
18 ARTHRALGIA 3865
19 PRURITUS 3790
20 COUGH 3546
21 ANXIETY 3419
22 FALL 3359
23 MALAISE 3340
24 CONSTIPATION 3305
25 GASTROOESOPHAGEAL REFLUX DISEASE 3073
26 WEIGHT DECREASED 3071
27 DECREASED APPETITE 3046
28 BACK PAIN 2938
29 PRODUCT DOSE OMISSION ISSUE 2811
30 ABDOMINAL PAIN 2787
31 PAIN IN EXTREMITY 2699
32 ABDOMINAL PAIN UPPER 2690
33 DEPRESSION 2583
34 INSOMNIA 2580
35 CHEST PAIN 2487
36 URINARY TRACT INFECTION 2471
37 END STAGE RENAL DISEASE 2440
38 CONDITION AGGRAVATED 2422
39 ANAEMIA 2405
40 HYPERTENSION 2358
41 HYPOTENSION 2338
42 URTICARIA 2263
43 PRODUCT USE IN UNAPPROVED INDICATION 2246
44 DYSPEPSIA 2229
45 COVID-19 2211
46 ABDOMINAL DISCOMFORT 2076
47 DEHYDRATION 2035
48 FEELING ABNORMAL 1958
49 PLATELET COUNT DECREASED 1877
50 RENAL INJURY 1840
51 MUSCLE SPASMS 1825
52 HYPERSENSITIVITY 1817
53 WEIGHT INCREASED 1740
54 BLOOD PRESSURE INCREASED 1732
55 ERYTHEMA 1724
56 PERIPHERAL SWELLING 1709
57 NASOPHARYNGITIS 1656
58 SOMNOLENCE 1649
59 GAIT DISTURBANCE 1631
60 TREMOR 1631
61 SEPSIS 1614
62 WHITE BLOOD CELL COUNT DECREASED 1603
63 MYALGIA 1591
64 ALOPECIA 1590
65 HYPOAESTHESIA 1557
66 CHEST DISCOMFORT 1528
67 CONFUSIONAL STATE 1519
68 HAEMOGLOBIN DECREASED 1496
69 OEDEMA PERIPHERAL 1455
70 FLUSHING 1440
71 ABDOMINAL DISTENSION 1415
72 CHILLS 1415
73 FEBRILE NEUTROPENIA 1381
74 DRUG INTERACTION 1372
75 PARAESTHESIA 1370
76 DRUG HYPERSENSITIVITY 1357
77 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1324
78 RENAL IMPAIRMENT 1315
79 SINUSITIS 1308
80 INFUSION RELATED REACTION 1293
81 ILLNESS 1286
82 INJECTION SITE PAIN 1284
83 INFECTION 1282
84 DYSPHAGIA 1251
85 ATRIAL FIBRILLATION 1242
86 HEART RATE INCREASED 1239
87 PALPITATIONS 1236
88 THROMBOCYTOPENIA 1231
89 HYPERHIDROSIS 1220
90 PRODUCT USE ISSUE 1219
91 INCORRECT DOSE ADMINISTERED 1213
92 NEUROPATHY PERIPHERAL 1206
93 MUSCULAR WEAKNESS 1201
94 NEUTROPENIA 1193
95 ANAPHYLACTIC REACTION 1185
96 VISION BLURRED 1173
97 ALANINE AMINOTRANSFERASE INCREASED 1167
98 CEREBROVASCULAR ACCIDENT 1141
99 DISEASE PROGRESSION 1141
100 ASTHMA 1127
101 RESPIRATORY FAILURE 1105
102 OROPHARYNGEAL PAIN 1102
103 TACHYCARDIA 1097
104 MYOCARDIAL INFARCTION 1095
105 ASPARTATE AMINOTRANSFERASE INCREASED 1084
106 INFLUENZA 1070
107 NEPHROGENIC ANAEMIA 1068
108 LOSS OF CONSCIOUSNESS 1054
109 MEMORY IMPAIRMENT 1047
110 CONTUSION 1045
111 HOSPITALISATION 1045
112 EMOTIONAL DISTRESS 1035
113 BRONCHITIS 1031
114 SWELLING 1009
115 MIGRAINE 1006
116 ARTHRITIS 1002
117 OSTEOPOROSIS 993
118 BLOOD GLUCOSE INCREASED 990
119 EPISTAXIS 976
120 PLEURAL EFFUSION 961
121 OXYGEN SATURATION DECREASED 959
122 BLOOD CREATININE INCREASED 943
123 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 940
124 SEIZURE 936
125 CARDIAC FAILURE CONGESTIVE 929
126 DRY MOUTH 924
127 PULMONARY EMBOLISM 914
128 SYNCOPE 907
129 GASTROINTESTINAL HAEMORRHAGE 905
130 TUBULOINTERSTITIAL NEPHRITIS 897
131 GASTROINTESTINAL DISORDER 890
132 BLOOD PRESSURE DECREASED 886
133 BALANCE DISORDER 863
134 NO ADVERSE EVENT 843
135 FLATULENCE 841
136 INJURY 828
137 JOINT SWELLING 826
138 STOMATITIS 826
139 DRY SKIN 824
140 DYSGEUSIA 816
141 HYPOKALAEMIA 814
142 UPPER RESPIRATORY TRACT INFECTION 813
143 CELLULITIS 811
144 MALIGNANT NEOPLASM PROGRESSION 808
145 DIABETES MELLITUS 790
146 NASAL CONGESTION 790
147 EXPOSURE DURING PREGNANCY 779
148 HEPATIC FUNCTION ABNORMAL 772
149 OVERDOSE 769
150 RHINORRHOEA 752
151 HOT FLUSH 741
152 CARDIAC ARREST 739
153 NEUTROPHIL COUNT DECREASED 735
154 THROMBOSIS 733
155 BONE PAIN 732
156 THROAT IRRITATION 730
157 DYSPHONIA 728
158 NECK PAIN 727
159 PANCYTOPENIA 724
160 INTERSTITIAL LUNG DISEASE 722
161 VISUAL IMPAIRMENT 717
162 HYPOXIA 712
163 STRESS 712
164 CARDIAC DISORDER 711
165 OSTEOARTHRITIS 711
166 EYE PAIN 705
167 SWELLING FACE 702
168 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 701
169 DEEP VEIN THROMBOSIS 695
170 THERAPEUTIC RESPONSE UNEXPECTED 691
171 REBOUND ACID HYPERSECRETION 690
172 HALLUCINATION 687
173 CARDIAC FAILURE 684
174 HAEMORRHAGE 683
175 OEDEMA 680
176 PRODUCTIVE COUGH 676
177 HYPONATRAEMIA 671
178 FEELING HOT 666
179 THERAPY INTERRUPTED 664
180 BURNING SENSATION 649
181 UNEVALUABLE EVENT 637
182 WHEEZING 634
183 WHITE BLOOD CELL COUNT INCREASED 633
184 GENERAL PHYSICAL HEALTH DETERIORATION 632
185 INJECTION SITE ERYTHEMA 628
186 RHEUMATOID ARTHRITIS 624
187 LIVER DISORDER 623
188 RENAL FAILURE ACUTE 619
189 SLEEP DISORDER 618
190 HERPES ZOSTER 616
191 INTENTIONAL PRODUCT USE ISSUE 615
192 CATARACT 613
193 LETHARGY 608
194 DYSPNOEA EXERTIONAL 598
195 MUSCULOSKELETAL STIFFNESS 595
196 DRY EYE 587
197 DRUG DOSE OMISSION 585
198 PULMONARY OEDEMA 581
199 NEPHROLITHIASIS 580
200 GASTRITIS 574
201 FLUID RETENTION 571
202 DRUG INTOLERANCE 566
203 RED BLOOD CELL COUNT DECREASED 566
204 RENAL DISORDER 560
205 BLOOD POTASSIUM DECREASED 559
206 SEPTIC SHOCK 548
207 SKIN EXFOLIATION 548
208 TOXICITY TO VARIOUS AGENTS 548
209 HEPATIC ENZYME INCREASED 545
210 DISCOMFORT 544
211 INFLUENZA LIKE ILLNESS 543
212 RASH PRURITIC 536
213 ANHEDONIA 533
214 HYPERPARATHYROIDISM SECONDARY 531
215 CHOLELITHIASIS 530
216 AMNESIA 525
217 BRADYCARDIA 525
218 EYE IRRITATION 522
219 INFUSION SITE PAIN 519
220 AGITATION 517
221 ADVERSE DRUG REACTION 515
222 BLISTER 515
223 PRODUCT QUALITY ISSUE 514
224 ACUTE RESPIRATORY FAILURE 508
225 VERTIGO 507
226 MOBILITY DECREASED 501
227 BLOOD ALKALINE PHOSPHATASE INCREASED 499
228 MENTAL STATUS CHANGES 497
229 SURGERY 491
230 PANCREATITIS 481
231 SPEECH DISORDER 480
232 ANGIOEDEMA 478
233 MUCOSAL INFLAMMATION 473
234 HAEMATOCRIT DECREASED 472
235 HAEMATOCHEZIA 468
236 LUNG DISORDER 467
237 IMPAIRED GASTRIC EMPTYING 466
238 CORONARY ARTERY DISEASE 465
239 MUSCULOSKELETAL PAIN 464
240 SUICIDAL IDEATION 463
241 HYPERKALAEMIA 460
242 INJECTION SITE SWELLING 459
243 COLITIS 458
244 THROAT TIGHTNESS 458
245 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 454
246 ADVERSE EVENT 452
247 RECTAL HAEMORRHAGE 451
248 VIRAL INFECTION 448
249 DYSURIA 445
250 BONE DISORDER 443
251 PSORIASIS 441
252 LIP SWELLING 440
253 TINNITUS 440
254 CONVULSION 439
255 POLLAKIURIA 438
256 SKIN DISCOLOURATION 437
257 PAIN IN JAW 436
258 BLOOD BILIRUBIN INCREASED 434
259 SEASONAL ALLERGY 434
260 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 424
261 BLOOD CHOLESTEROL INCREASED 421
262 IRRITABILITY 421
263 PNEUMONIA ASPIRATION 420
264 CYSTITIS 415
265 LEUKOPENIA 415
266 C-REACTIVE PROTEIN INCREASED 411
267 DISEASE RECURRENCE 411
268 SWOLLEN TONGUE 411
269 INTESTINAL OBSTRUCTION 409
270 OSTEOPENIA 409
271 CARDIO-RESPIRATORY ARREST 408
272 THERAPY NON-RESPONDER 408
273 INJECTION SITE BRUISING 407
274 LYMPHOCYTE COUNT DECREASED 407
275 MULTIPLE FRACTURES 407
276 ARTHROPATHY 406
277 BLOOD UREA INCREASED 405
278 RHABDOMYOLYSIS 405
279 HAEMOPTYSIS 402
280 INTENTIONAL PRODUCT MISUSE 398
281 CYTOKINE RELEASE SYNDROME 394
282 DELIRIUM 393
283 BLOOD LACTATE DEHYDROGENASE INCREASED 391
284 DISORIENTATION 391
285 TRANSIENT ISCHAEMIC ATTACK 391
286 HYPERGLYCAEMIA 390
287 INJECTION SITE REACTION 390
288 NERVOUSNESS 390
289 DEPRESSED LEVEL OF CONSCIOUSNESS 389
290 PRODUCT DOSE OMISSION IN ERROR 387
291 STAPHYLOCOCCAL INFECTION 386
292 DEPRESSED MOOD 384
293 THERAPY CESSATION 382
294 RASH ERYTHEMATOUS 381
295 ECZEMA 380
296 HYPOTHYROIDISM 379
297 ASCITES 377
298 DISSEMINATED INTRAVASCULAR COAGULATION 377
299 ARRHYTHMIA 376
300 THERAPEUTIC RESPONSE DECREASED 376
301 NEOPLASM MALIGNANT 375
302 HYPOGLYCAEMIA 374
303 PANIC ATTACK 373
304 HAEMATURIA 372
305 EYE SWELLING 370
306 INJECTION SITE PRURITUS 369
307 VITAMIN D DEFICIENCY 365
308 DYSARTHRIA 364
309 FOOT FRACTURE 364
310 TREATMENT NONCOMPLIANCE 364
311 BONE DENSITY DECREASED 362
312 INTENTIONAL DOSE OMISSION 362
313 LYMPHADENOPATHY 362
314 PULMONARY HYPERTENSION 362
315 RESPIRATORY DISTRESS 362
316 HEART RATE DECREASED 361
317 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 359
318 ILL-DEFINED DISORDER 359
319 MATERNAL EXPOSURE DURING PREGNANCY 359
320 PLASMA CELL MYELOMA 358
321 ECONOMIC PROBLEM 357
322 INFLAMMATION 357
323 OCULAR HYPERAEMIA 356
324 ACUTE MYOCARDIAL INFARCTION 355
325 IMPAIRED QUALITY OF LIFE 354
326 DEVICE ISSUE 353
327 ENCEPHALOPATHY 349
328 URINARY INCONTINENCE 348
329 COGNITIVE DISORDER 347
330 SKIN DISORDER 347
331 EAR INFECTION 345
332 URINARY RETENTION 345
333 BRAIN FOG 343
334 FAECES DISCOLOURED 343
335 INTERNATIONAL NORMALISED RATIO INCREASED 343
336 INTERVERTEBRAL DISC PROTRUSION 343
337 CEREBRAL HAEMORRHAGE 342
338 GASTRIC DISORDER 342
339 HYPOMAGNESAEMIA 342
340 PNEUMONITIS 341
341 DIVERTICULITIS 339
342 HIP FRACTURE 339
343 HEAD INJURY 338
344 RESPIRATORY TRACT INFECTION 336
345 DISTURBANCE IN ATTENTION 335
346 ELECTROCARDIOGRAM QT PROLONGED 335
347 HYPERSOMNIA 334
348 HYPOPHAGIA 333
349 LIMB DISCOMFORT 332
350 TASTE DISORDER 331
351 DYSKINESIA 330
352 INFUSION SITE ERYTHEMA 330
353 LIMB INJURY 329
354 NEPHROPATHY 329
355 LABORATORY TEST ABNORMAL 328
356 ORAL PAIN 328
357 ROAD TRAFFIC ACCIDENT 328
358 ANGINA PECTORIS 327
359 FUNGAL INFECTION 327
360 HYPERLIPIDAEMIA 322
361 BLOOD GLUCOSE DECREASED 321
362 SLEEP APNOEA SYNDROME 321
363 LACRIMATION INCREASED 320
364 RASH MACULAR 320
365 ACCIDENTAL EXPOSURE TO PRODUCT 319
366 CROHN^S DISEASE 319
367 GALLBLADDER DISORDER 318
368 RESTLESSNESS 318
369 APLASTIC ANAEMIA 317
370 HIATUS HERNIA 317
371 CEREBRAL INFARCTION 314
372 NIGHT SWEATS 314
373 ACCIDENTAL OVERDOSE 313
374 UNDERDOSE 313
375 UNRESPONSIVE TO STIMULI 312
376 BLOOD SODIUM DECREASED 311
377 ERUCTATION 310
378 VENTRICULAR TACHYCARDIA 310
379 SKIN ULCER 309
380 GASTRIC ULCER 308
381 RENAL TUBULAR NECROSIS 308
382 ATELECTASIS 307
383 MENTAL DISORDER 307
384 PRODUCT DOSE OMISSION 307
385 RETCHING 307
386 MULTIPLE SCLEROSIS RELAPSE 306
387 NEURALGIA 306
388 GAIT INABILITY 305
389 TYPE 2 DIABETES MELLITUS 305
390 DYSSTASIA 304
391 INFUSION SITE SWELLING 304
392 RIB FRACTURE 304
393 HAEMORRHOIDS 303
394 RESPIRATORY DISORDER 303
395 CLOSTRIDIUM DIFFICILE INFECTION 302
396 GAMMA-GLUTAMYLTRANSFERASE INCREASED 301
397 METABOLIC ACIDOSIS 300
398 ANAPHYLACTIC SHOCK 297
399 LEUKOCYTOSIS 295
400 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 292
401 DERMATITIS ATOPIC 291
402 FEELING COLD 289
403 IRRITABLE BOWEL SYNDROME 289
404 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 288
405 SINUS DISORDER 288
406 HAEMATEMESIS 287
407 POOR QUALITY SLEEP 285
408 EYE PRURITUS 284
409 MULTI-ORGAN FAILURE 283
410 IMPAIRED HEALING 282
411 INTERVERTEBRAL DISC DEGENERATION 282
412 BLOOD CREATINE PHOSPHOKINASE INCREASED 281
413 PRODUCT SUBSTITUTION ISSUE 279
414 BLOOD PRESSURE ABNORMAL 276
415 FULL BLOOD COUNT DECREASED 276
416 PNEUMOTHORAX 272
417 SPINAL OSTEOARTHRITIS 272
418 MEDICATION ERROR 271
419 EAR PAIN 270
420 HEPATIC FAILURE 269
421 HYPOACUSIS 269
422 PHARYNGEAL SWELLING 269
423 HEPATIC STEATOSIS 267
424 PERICARDIAL EFFUSION 266
425 PRESYNCOPE 266
426 APHASIA 265
427 HEART RATE IRREGULAR 264
428 JOINT INJURY 263
429 SINUS TACHYCARDIA 263
430 EATING DISORDER 260
431 INCORRECT PRODUCT ADMINISTRATION DURATION 260
432 FEAR 259
433 DERMATITIS CONTACT 258
434 FIBROMYALGIA 258
435 JAUNDICE 257
436 FEEDING DISORDER 256
437 INSURANCE ISSUE 256
438 BLOOD PRESSURE FLUCTUATION 255
439 LACTIC ACIDOSIS 252
440 LOCALISED INFECTION 252
441 INJECTION SITE HAEMORRHAGE 251
442 GASTROENTERITIS VIRAL 249
443 HAEMATOMA 249
444 DEVICE MALFUNCTION 248
445 MUSCULOSKELETAL CHEST PAIN 248
446 MUSCULOSKELETAL DISCOMFORT 248
447 STEVENS-JOHNSON SYNDROME 248
448 BLOOD POTASSIUM INCREASED 247
449 FEMUR FRACTURE 247
450 HYPOCALCAEMIA 247
451 POST PROCEDURAL COMPLICATION 247
452 ALTERED STATE OF CONSCIOUSNESS 245
453 PANCREATITIS ACUTE 245
454 SHOCK 245
455 CARDIOMEGALY 244
456 DRUG-INDUCED LIVER INJURY 244
457 OSTEOMYELITIS 243
458 MITRAL VALVE INCOMPETENCE 241
459 BLOOD URINE PRESENT 240
460 LIVER FUNCTION TEST ABNORMAL 240
461 CHROMATURIA 239
462 CRYING 239
463 EXPIRED PRODUCT ADMINISTERED 237
464 ACUTE RESPIRATORY DISTRESS SYNDROME 236
465 ANKLE FRACTURE 236
466 THERAPEUTIC PRODUCT EFFECT DECREASED 236
467 DEMENTIA 235
468 ACNE 234
469 GOUT 233
470 NEOPLASM PROGRESSION 233
471 RESTLESS LEGS SYNDROME 233
472 SKIN BURNING SENSATION 232
473 HEREDITARY ANGIOEDEMA 231
474 TOOTH DISORDER 231
475 OSTEONECROSIS OF JAW 229
476 AGGRESSION 228
477 COMPLETED SUICIDE 228
478 TOXIC EPIDERMAL NECROLYSIS 228
479 AGEUSIA 227
480 GASTROENTERITIS 227
481 MULTIPLE SCLEROSIS 227
482 BACTERIAL INFECTION 226
483 BREAST CANCER 226
484 CARPAL TUNNEL SYNDROME 226
485 EMOTIONAL DISORDER 226
486 SKIN LESION 226
487 UPPER GASTROINTESTINAL HAEMORRHAGE 226
488 BLOOD MAGNESIUM DECREASED 225
489 WOUND 225
490 BODY TEMPERATURE INCREASED 224
491 RESPIRATORY ARREST 223
492 ILEUS 222
493 DRUG ERUPTION 221
494 ORAL CANDIDIASIS 221
495 ANOREXIA 220
496 SPINAL FRACTURE 220
497 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 219
498 MELAENA 219
499 SMALL INTESTINAL OBSTRUCTION 219
500 DRUG EFFECT DECREASED 218
501 PRODUCT ADMINISTRATION INTERRUPTED 217
502 MALNUTRITION 216
503 SNEEZING 216
504 ORAL HERPES 215
505 PHOTOPHOBIA 215
506 ABNORMAL BEHAVIOUR 214
507 PROTEINURIA 214
508 ULCER 214
509 TOOTHACHE 213
510 HERNIA 212
511 NIGHTMARE 211
512 PALLOR 211
513 RESPIRATORY TRACT CONGESTION 211
514 ROTATOR CUFF SYNDROME 211
515 CLOSTRIDIUM DIFFICILE COLITIS 210
516 CHOLECYSTITIS CHRONIC 209
517 PROCEDURAL PAIN 208
518 WEIGHT FLUCTUATION 208
519 CONTRAINDICATED PRODUCT ADMINISTERED 206
520 DIPLOPIA 206
521 KIDNEY INFECTION 205
522 MIDDLE INSOMNIA 205
523 COAGULOPATHY 204
524 MAST CELL ACTIVATION SYNDROME 204
525 BLOOD PRESSURE SYSTOLIC INCREASED 203
526 LOWER LIMB FRACTURE 203
527 PRODUCT PHYSICAL ISSUE 203
528 EYE DISORDER 202
529 IMPAIRED WORK ABILITY 202
530 HALLUCINATION, VISUAL 201
531 MOVEMENT DISORDER 201
532 HOSPICE CARE 200
533 TREATMENT FAILURE 200
534 DEAFNESS 199
535 DRUG WITHDRAWAL SYNDROME 199
536 METASTASES TO LIVER 199
537 INCORRECT DRUG ADMINISTRATION DURATION 198
538 JOINT STIFFNESS 198
539 PULMONARY MASS 198
540 COMA 196
541 INJECTION SITE RASH 196
542 ABDOMINAL PAIN LOWER 195
543 BACK DISORDER 194
544 CHOLECYSTITIS 194
545 FACE OEDEMA 194
546 PSORIATIC ARTHROPATHY 194
547 COVID-19 PNEUMONIA 193
548 DEVICE RELATED INFECTION 193
549 THIRST 193
550 BACTERAEMIA 192
551 BLOOD TRIGLYCERIDES INCREASED 192
552 NOCTURIA 192
553 OSTEONECROSIS 192
554 TRICUSPID VALVE INCOMPETENCE 192
555 CANDIDA INFECTION 191
556 NEUTROPHIL COUNT INCREASED 191
557 ORAL DISCOMFORT 191
558 PARAESTHESIA ORAL 191
559 RASH MACULO-PAPULAR 191
560 CORONARY ARTERY OCCLUSION 190
561 PRODUCT STORAGE ERROR 190
562 THERAPEUTIC RESPONSE SHORTENED 190
563 MULTIPLE ORGAN DYSFUNCTION SYNDROME 189
564 OBESITY 189
565 BLOOD ALBUMIN DECREASED 188
566 DEVICE DISLOCATION 188
567 DRUG EFFECT LESS THAN EXPECTED 188
568 PROSTATE CANCER 188
569 EXTRA DOSE ADMINISTERED 187
570 LIVER FUNCTION TEST INCREASED 187
571 SYSTEMIC LUPUS ERYTHEMATOSUS 187
572 SCIATICA 186
573 THYROID DISORDER 186
574 BLOOD CALCIUM DECREASED 185
575 GASTRIC CANCER 185
576 MUSCLE TIGHTNESS 184
577 COLITIS ULCERATIVE 183
578 CYANOSIS 183
579 OESOPHAGITIS 183
580 RASH GENERALISED 183
581 DRUG DEPENDENCE 182
582 SCAR 182
583 BLINDNESS 181
584 FEELING JITTERY 181
585 GLOSSODYNIA 181
586 UPPER LIMB FRACTURE 181
587 GENERALISED OEDEMA 180
588 PULMONARY FIBROSIS 180
589 SUICIDE ATTEMPT 180
590 HEAD DISCOMFORT 178
591 MOUTH ULCERATION 178
592 SEROTONIN SYNDROME 178
593 ELECTROLYTE IMBALANCE 177
594 FREQUENT BOWEL MOVEMENTS 177
595 DERMATITIS 176
596 HYPOAESTHESIA ORAL 176
597 NERVOUS SYSTEM DISORDER 176
598 BLOOD IRON DECREASED 175
599 DECREASED ACTIVITY 175
600 METASTASES TO BONE 175
601 FLUID OVERLOAD 174
602 LOWER RESPIRATORY TRACT INFECTION 174
603 TACHYPNOEA 174
604 TORSADE DE POINTES 174
605 ORTHOSTATIC HYPOTENSION 173
606 WRIST FRACTURE 173
607 CHOKING 172
608 GLAUCOMA 172
609 HAIR COLOUR CHANGES 171
610 HEMIPARESIS 171
611 HYPOALBUMINAEMIA 171
612 RENAL FAILURE CHRONIC 171
613 CONJUNCTIVITIS 170
614 LUNG INFILTRATION 170
615 MUSCLE TWITCHING 170
616 PNEUMONIA BACTERIAL 170
617 RASH PAPULAR 170
618 SINUS CONGESTION 170
619 VENTRICULAR EXTRASYSTOLES 170
620 CARDIOMYOPATHY 169
621 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 169
622 CHOLECYSTITIS ACUTE 168
623 FOOD ALLERGY 168
624 LUNG NEOPLASM MALIGNANT 168
625 PLATELET COUNT INCREASED 168
626 SPINAL COMPRESSION FRACTURE 168
627 ABNORMAL DREAMS 167
628 HYPOPHOSPHATAEMIA 167
629 INFUSION SITE HAEMORRHAGE 167
630 RENAL CYST 167
631 FLANK PAIN 166
632 IRON DEFICIENCY ANAEMIA 166
633 MOOD ALTERED 166
634 MOUTH HAEMORRHAGE 166
635 VISUAL ACUITY REDUCED 165
636 ARTERIOSCLEROSIS 164
637 GLYCOSYLATED HAEMOGLOBIN INCREASED 164
638 TOOTH LOSS 164
639 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 162
640 MULTIPLE ALLERGIES 162
641 OROPHARYNGEAL DISCOMFORT 162
642 PRODUCT USE COMPLAINT 162
643 SKIN LACERATION 162
644 UPPER-AIRWAY COUGH SYNDROME 162
645 PULMONARY ARTERIAL HYPERTENSION 161
646 TENDERNESS 160
647 VAGINAL HAEMORRHAGE 160
648 BURSITIS 159
649 LIGAMENT SPRAIN 159
650 PERIPHERAL COLDNESS 159
651 PULMONARY CONGESTION 159
652 QUALITY OF LIFE DECREASED 159
653 COLD SWEAT 158
654 SPLENOMEGALY 158
655 SUBDURAL HAEMATOMA 158
656 CARDIOVASCULAR DISORDER 157
657 DIZZINESS POSTURAL 157
658 TRANSAMINASES INCREASED 157
659 HYPERVOLAEMIA 156
660 URINE OUTPUT DECREASED 156
661 ADRENAL INSUFFICIENCY 155
662 HAIR TEXTURE ABNORMAL 155
663 IMMUNODEFICIENCY 155
664 PERITONITIS 155
665 SEDATION 155
666 TOOTH INFECTION 155
667 ANGER 154
668 BONE MARROW FAILURE 154
669 DENTAL CARIES 154
670 HEPATITIS 154
671 PRODUCT AVAILABILITY ISSUE 154
672 NERVE COMPRESSION 153
673 RESPIRATORY SYNCYTIAL VIRUS INFECTION 153
674 SUPRAVENTRICULAR TACHYCARDIA 153
675 EMPHYSEMA 152
676 INCREASED TENDENCY TO BRUISE 152
677 PRESCRIBED UNDERDOSE 152
678 HEPATIC CIRRHOSIS 151
679 DECUBITUS ULCER 150
680 EXPOSURE VIA SKIN CONTACT 150
681 MASS 150
682 PHARYNGITIS 150
683 POOR VENOUS ACCESS 150
684 TRANSFUSION 150
685 BIPOLAR DISORDER 149
686 SKIN FISSURES 149
687 DIVERTICULUM 148
688 CYTOMEGALOVIRUS INFECTION 147
689 DRY THROAT 147
690 GLOMERULAR FILTRATION RATE DECREASED 147
691 INFUSION SITE PRURITUS 146
692 PSYCHOLOGICAL TRAUMA 146
693 SARS-COV-2 TEST POSITIVE 146
694 VENTRICULAR FIBRILLATION 146
695 BLOOD TEST ABNORMAL 145
696 HYPERCALCAEMIA 145
697 ASPIRATION 144
698 DIABETIC KETOACIDOSIS 144
699 DIALYSIS 144
700 DRUG LEVEL INCREASED 144
701 KNEE ARTHROPLASTY 144
702 TOOTH FRACTURE 144
703 WITHDRAWAL SYNDROME 144
704 AGRANULOCYTOSIS 143
705 COORDINATION ABNORMAL 143
706 FOETAL EXPOSURE DURING PREGNANCY 143
707 INCREASED APPETITE 143
708 PURPURA 143
709 SECRETION DISCHARGE 143
710 SINUS BRADYCARDIA 143
711 BODY HEIGHT DECREASED 142
712 DEVICE LEAKAGE 142
713 DRUG EFFECT INCOMPLETE 142
714 MICTURITION URGENCY 142
715 PRODUCT ADMINISTRATION ERROR 142
716 COMPLICATION ASSOCIATED WITH DEVICE 141
717 NEEDLE ISSUE 141
718 POST-TRAUMATIC STRESS DISORDER 141
719 TEMPERATURE INTOLERANCE 141
720 EOSINOPHIL COUNT INCREASED 140
721 RENAL CANCER 140
722 BRONCHOSPASM 139
723 DELUSION 139
724 HAEMORRHAGE INTRACRANIAL 138
725 INCONTINENCE 138
726 MYOCARDIAL ISCHAEMIA 138
727 BACK INJURY 137
728 CHOLECYSTECTOMY 137
729 EJECTION FRACTION DECREASED 137
730 GASTROINTESTINAL PAIN 137
731 MENTAL IMPAIRMENT 137
732 GINGIVAL BLEEDING 136
733 INFUSION SITE DISCHARGE 136
734 MOOD SWINGS 136
735 CALCIUM DEFICIENCY 135
736 DISABILITY 135
737 INTERNAL HAEMORRHAGE 135
738 PHOTOSENSITIVITY REACTION 135
739 TUMOUR LYSIS SYNDROME 135
740 COLON CANCER 134
741 GLUCOSE TOLERANCE IMPAIRED 134
742 PRURITUS GENERALISED 134
743 TENDONITIS 134
744 ABSCESS 133
745 ACCIDENTAL DRUG INTAKE BY CHILD 133
746 BASAL CELL CARCINOMA 133
747 CIRCULATORY COLLAPSE 133
748 DIABETES MELLITUS INADEQUATE CONTROL 133
749 OCULAR DISCOMFORT 133
750 SCOLIOSIS 133
751 SPINAL OPERATION 133
752 APHONIA 132
753 FRACTURE 132
754 HYPERCHOLESTEROLAEMIA 132
755 HYPOVOLAEMIA 131
756 NEUROTOXICITY 131
757 SKIN IRRITATION 131
758 SPINAL DISORDER 130
759 TOOTH EXTRACTION 130
760 BLADDER CANCER 129
761 BLOOD COUNT ABNORMAL 129
762 BRAIN OEDEMA 129
763 WRONG TECHNIQUE IN DRUG USAGE PROCESS 129
764 ABORTION SPONTANEOUS 128
765 EAR DISCOMFORT 128
766 PAIN OF SKIN 128
767 PRESCRIBED OVERDOSE 128
768 SKIN CANCER 128
769 HYPERBILIRUBINAEMIA 127
770 URINE ABNORMALITY 127
771 HAEMOGLOBIN INCREASED 126
772 HICCUPS 126
773 INJECTION SITE URTICARIA 126
774 METASTASES TO LUNG 126
775 PRODUCT PRESCRIBING ISSUE 126
776 ACTIVITIES OF DAILY LIVING IMPAIRED 125
777 ANAL INCONTINENCE 125
778 DRUG ADMINISTRATION ERROR 125
779 ERYTHEMA MULTIFORME 125
780 PHARYNGEAL OEDEMA 125
781 PSEUDOMONAS INFECTION 125
782 PSYCHOTIC DISORDER 125
783 RHINOVIRUS INFECTION 125
784 TARDIVE DYSKINESIA 125
785 TOOTH ABSCESS 125
786 EXOSTOSIS 124
787 HAND FRACTURE 124
788 PARKINSON^S DISEASE 123
789 PELVIC PAIN 123
790 PEPTIC ULCER 123
791 THINKING ABNORMAL 123
792 ATRIAL FLUTTER 122
793 DEVICE OCCLUSION 122
794 ENTEROCOLITIS 122
795 INJECTION SITE MASS 122
796 MUSCLE ATROPHY 122
797 PANCREATIC CARCINOMA 122
798 CARDIOGENIC SHOCK 121
799 LOCAL SWELLING 121
800 PRODUCT DISTRIBUTION ISSUE 121
801 SKIN HAEMORRHAGE 121
802 UROSEPSIS 121
803 CARDIAC MURMUR 120
804 PRODUCT TASTE ABNORMAL 120
805 RESPIRATORY RATE INCREASED 120
806 SENSATION OF FOREIGN BODY 120
807 VASCULAR DEVICE INFECTION 120
808 VITAMIN B12 DEFICIENCY 120
809 VITAMIN D DECREASED 120
810 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 119
811 HYDRONEPHROSIS 119
812 SKIN INFECTION 119
813 SPUTUM DISCOLOURED 119
814 VITREOUS FLOATERS 119
815 ABASIA 118
816 EYE INFECTION 118
817 GINGIVAL PAIN 118
818 ACIDOSIS 117
819 EPILEPSY 117
820 HAEMODIALYSIS 117
821 METASTASES TO CENTRAL NERVOUS SYSTEM 117
822 MUSCULOSKELETAL DISORDER 117
823 NERVE INJURY 117
824 ELECTROCARDIOGRAM ABNORMAL 116
825 EOSINOPHILIA 116
826 HAEMOLYTIC ANAEMIA 116
827 HEPATOMEGALY 116
828 INITIAL INSOMNIA 116
829 LARYNGITIS 116
830 PERIORBITAL SWELLING 116
831 PETECHIAE 116
832 PRE-EXISTING CONDITION IMPROVED 116
833 ACUTE MYELOID LEUKAEMIA 115
834 CYST 115
835 MADAROSIS 115
836 CYTOPENIA 114
837 MONOCYTE COUNT INCREASED 114
838 PARALYSIS 114
839 SUBARACHNOID HAEMORRHAGE 114
840 ANGINA UNSTABLE 113
841 BLOOD THYROID STIMULATING HORMONE INCREASED 112
842 PROTHROMBIN TIME PROLONGED 112
843 BLOOD URIC ACID INCREASED 111
844 DRUG ABUSE 111
845 DRUG SCREEN POSITIVE 111
846 ECCHYMOSIS 111
847 GASTROINTESTINAL INFECTION 111
848 PHARYNGITIS STREPTOCOCCAL 111
849 BLADDER DISORDER 110
850 BODY TEMPERATURE DECREASED 110
851 EYE DISCHARGE 110
852 POLYP 110
853 COMPRESSION FRACTURE 109
854 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 109
855 INTENTIONAL OVERDOSE 109
856 RHINITIS ALLERGIC 109
857 BONE LOSS 108
858 DIVERTICULUM INTESTINAL 108
859 ERECTILE DYSFUNCTION 108
860 GROIN PAIN 108
861 LEFT VENTRICULAR HYPERTROPHY 108
862 LYMPHOPENIA 108
863 PHARMACEUTICAL PRODUCT COMPLAINT 108
864 PRODUCT PRESCRIBING ERROR 108
865 RED CELL DISTRIBUTION WIDTH INCREASED 108
866 AORTIC VALVE INCOMPETENCE 107
867 NODULE 107
868 PARANOIA 107
869 PROTEIN URINE PRESENT 107
870 PULMONARY THROMBOSIS 107
871 INTESTINAL PERFORATION 106
872 TROPONIN INCREASED 106
873 BLOOD PRESSURE DIASTOLIC DECREASED 105
874 ESSENTIAL HYPERTENSION 105
875 FACIAL PAIN 105
876 FULL BLOOD COUNT ABNORMAL 105
877 HYPERURICAEMIA 105
878 MUSCLE STRAIN 105
879 POST PROCEDURAL HAEMORRHAGE 105
880 ARTHROPOD BITE 104
881 MYELODYSPLASTIC SYNDROME 104
882 ARTERIOSCLEROSIS CORONARY ARTERY 103
883 BLOOD CALCIUM INCREASED 103
884 LIVER INJURY 103
885 BEDRIDDEN 102
886 HYPERCHLORHYDRIA 102
887 LOWER GASTROINTESTINAL HAEMORRHAGE 102
888 MAJOR DEPRESSION 102
889 MYASTHENIA GRAVIS 102
890 APPETITE DISORDER 101
891 JOINT DISLOCATION 101
892 TONGUE DISORDER 101
893 BONE LESION 100
894 HIP ARTHROPLASTY 100
895 IMMUNE SYSTEM DISORDER 100
896 JOINT RANGE OF MOTION DECREASED 100
897 MYELOSUPPRESSION 100
898 PATHOLOGICAL FRACTURE 100
899 PERIPHERAL VASCULAR DISORDER 100
900 SPINAL PAIN 100
901 ATAXIA 99
902 BOWEL MOVEMENT IRREGULARITY 99
903 FAILURE TO THRIVE 99
904 HAIR DISORDER 99
905 SYNOVIAL CYST 99
906 DEVICE INFUSION ISSUE 98
907 POLYURIA 98
908 PROTEIN TOTAL DECREASED 98
909 PYELONEPHRITIS 98
910 RESPIRATION ABNORMAL 98
911 RIGHT VENTRICULAR FAILURE 98
912 LYMPHOMA 97
913 MYOCLONUS 97
914 SALIVARY HYPERSECRETION 97
915 DIABETIC NEUROPATHY 96
916 DRUG TOXICITY 96
917 HUNGER 96
918 EMBOLISM 95
919 GENERALISED TONIC-CLONIC SEIZURE 95
920 HYPERTHYROIDISM 95
921 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 95
922 THERAPY PARTIAL RESPONDER 95
923 TYPE I HYPERSENSITIVITY 95
924 ACUTE CORONARY SYNDROME 94
925 CONCOMITANT DISEASE AGGRAVATED 94
926 DEVICE DIFFICULT TO USE 94
927 DRUG EXPOSURE DURING PREGNANCY 94
928 INFUSION SITE EXTRAVASATION 94
929 WALKING AID USER 94
930 WOUND INFECTION 94
931 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 94
932 ABDOMINAL TENDERNESS 93
933 ATRIOVENTRICULAR BLOCK COMPLETE 93
934 AUTOIMMUNE DISORDER 93
935 COLITIS ISCHAEMIC 93
936 HALLUCINATION, AUDITORY 93
937 HEPATIC ENCEPHALOPATHY 93
938 HYPERKERATOSIS 93
939 PRODUCT DISPENSING ERROR 93
940 PROSTATIC SPECIFIC ANTIGEN INCREASED 93
941 STAPHYLOCOCCAL BACTERAEMIA 93
942 STAPHYLOCOCCAL SEPSIS 93
943 ACUTE HEPATIC FAILURE 92
944 ADVERSE REACTION 92
945 BLOOD GLUCOSE ABNORMAL 92
946 DERMATITIS ACNEIFORM 92
947 DEVICE BREAKAGE 92
948 DUODENAL ULCER 92
949 FOOT DEFORMITY 92
950 HYPOKINESIA 92
951 SENSORY DISTURBANCE 92
952 VASCULITIS 92
953 BLOOD PRESSURE SYSTOLIC DECREASED 91
954 DERMATITIS ALLERGIC 91
955 PROCTALGIA 91
956 RHINITIS 91
957 THERAPY CHANGE 91
958 FAECES SOFT 90
959 MACULAR DEGENERATION 90
960 PHYSICAL DISABILITY 90
961 SYNOVITIS 90
962 WHITE BLOOD CELL COUNT ABNORMAL 90
963 INFUSION SITE BRUISING 89
964 KIDNEY TRANSPLANT REJECTION 89
965 POSTOPERATIVE WOUND INFECTION 89
966 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 88
967 CULTURE URINE POSITIVE 88
968 CYSTIC FIBROSIS 88
969 GASTRIC HAEMORRHAGE 88
970 GASTROINTESTINAL MOTILITY DISORDER 88
971 HEART RATE ABNORMAL 88
972 RALES 88
973 CARDIAC FAILURE ACUTE 87
974 ESCHERICHIA INFECTION 87
975 EXTRAPYRAMIDAL DISORDER 87
976 GASTROINTESTINAL HYPOMOTILITY 87
977 INFUSION SITE REACTION 87
978 LARGE INTESTINE PERFORATION 87
979 LYMPHOEDEMA 87
980 NEOPLASM 87
981 OBSTRUCTIVE AIRWAYS DISORDER 87
982 PRODUCT PACKAGING ISSUE 87
983 SKIN REACTION 87
984 BLOOD CREATININE DECREASED 86
985 MENISCUS INJURY 86
986 OLIGURIA 86
987 RED BLOOD CELL SEDIMENTATION RATE INCREASED 86
988 BLINDNESS UNILATERAL 85
989 CARDIAC FLUTTER 85
990 DRUG DOSE OMISSION BY DEVICE 85
991 FAECALOMA 85
992 NAIL DISORDER 85
993 APPENDICITIS 84
994 DYSLIPIDAEMIA 84
995 DYSTONIA 84
996 HEMIPLEGIA 84
997 LARGE INTESTINE POLYP 84
998 LIPASE INCREASED 84
999 SHOCK HAEMORRHAGIC 84